Clinical Trial Update: A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy of Taclonex Topical Suspension as an adjunct to non-biologic systemic therapy in psoriasis; the study has been completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Taclonex Topical Suspension (calcipotriene and betamethasone dipropionate)

Snippet

Sponsor: University of Pittsburgh | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2016-09-21